Israel Englander Rapt Therapeutics, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 242,155 shares of RAPT stock, worth $971,041. This represents 0.0% of its overall portfolio holdings.

Number of Shares

242,155

Previous 444,751 45.55%

Holding current value

$971,041

Previous $11.1 Million 80.33%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$6.87 - $26.45 $1.39 Million - $5.36 Million	-202,596 Reduced 45.55%	242,155 $2.17 Million
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $3.69 Million - $8.32 Million	326,959 Added 277.57%	444,751 $11.1 Million
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $776,918 - $1.05 Million	48,376 Added 69.69%	117,792 $2.2 Million
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $254,583 - $456,148	14,810 Added 27.12%	69,416 $1.27 Million
Q4 2022 Feb 14, 2023	SELL	$16.28 - $24.6 $809,409 - $1.22 Million	-49,718 Reduced 47.66%	54,606 $1.08 Million

Q3 2022 Nov 14, 2022	SELL	$17.96 - $30.46 $1.37 Million - $2.33 Million	-76,367 Reduced 42.26%	104,324 $2.51 Million
Q2 2022 Aug 15, 2022	BUY	$10.26 - $23.59 $1.05 Million - $2.41 Million	102,170 Added 130.12%	180,691 $3.3 Million
Q1 2022 May 16, 2022	BUY	$17.02 - $40.22 $832,669 - $1.97 Million	48,923 Added 165.29%	78,521 $1.73 Million
Q4 2021 Feb 14, 2022	SELL	$29.5 - $39.5 $13.8 Million - $18.4 Million	-466,809 Reduced 94.04%	29,598 $1.09 Million
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $4.61 Million - $6.1 Million	154,435 Added 45.16%	496,407 $15.4 Million
Q2 2021 Aug 16, 2021	SELL	$17.99 - $40.02 $1.42 Million - $3.15 Million	-78,783 Reduced 18.72%	341,972 $10.9 Million
Q1 2021 May 17, 2021	BUY	$16.0 - $24.46 $1.19 Million - $1.81 Million	74,092 Added 21.37%	420,755 $9.34 Million
Q4 2020 Feb 16, 2021	BUY	$15.89 - $40.87 $2.57 Million - $6.61 Million	161,718 Added 87.44%	346,663 $6.85 Million
Q3 2020 Nov 16, 2020	BUY	$21.6 - $37.5 $3.22 Million - $5.6 Million	149,293 Added 418.75%	184,945 $5.96 Million
Q2 2020 Aug 14, 2020	SELL	$14.16 - $32.85 $122,696 - $284,645	-8,665 Reduced 19.55%	35,652 $1.04 Million
Q1 2020 May 14, 2020	BUY	$11.86 - $48.86 $525,599 - $2.17 Million	44,317 New	44,317 $943,000

Others Institutions Holding RAPT

# of Institutions

148

Shares Held

29.2M

Call Options Held

709K

Put Options Held

1.06M

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $119M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account